These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 23171950)

  • 21. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
    Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H
    FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of antimicrobial peptide mimetics in the oral cavity: I. Activity against biofilms of Candida albicans.
    Hua J; Yamarthy R; Felsenstein S; Scott RW; Markowitz K; Diamond G
    Mol Oral Microbiol; 2010 Dec; 25(6):418-25. PubMed ID: 21040515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of four calcium channel blockers as fluconazole resistance inhibitors in Candida glabrata.
    Alnajjar LM; Bulatova NR; Darwish RM
    J Glob Antimicrob Resist; 2018 Sep; 14():185-189. PubMed ID: 29665423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of the combination of tyrosol with chlorhexidine gluconate on oral biofilms.
    do Vale LR; Delbem A; Arias LS; Fernandes RA; Vieira A; Barbosa DB; Monteiro DR
    Oral Dis; 2017 May; 23(4):537-541. PubMed ID: 28142218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans.
    Khan MS; Malik A; Ahmad I
    Med Mycol; 2012 Jan; 50(1):33-42. PubMed ID: 21756200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of human serum on antifungal pharmacodynamics with Candida albicans.
    Zhanel GG; Saunders DG; Hoban DJ; Karlowsky JA
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2018-22. PubMed ID: 11408217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of fluconazole and amphotericin B against Candida inconspicua clinical isolates as determined by the time-kill method.
    Szabó Z; Sóczó G; Miszti C; Hermann P; Rozgonyi F
    Acta Microbiol Immunol Hung; 2008 Mar; 55(1):53-61. PubMed ID: 18507151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle.
    Zore GB; Thakre AD; Jadhav S; Karuppayil SM
    Phytomedicine; 2011 Oct; 18(13):1181-90. PubMed ID: 21596542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antimicrobial properties of coconut oil on Candida species in Ibadan, Nigeria.
    Ogbolu DO; Oni AA; Daini OA; Oloko AP
    J Med Food; 2007 Jun; 10(2):384-7. PubMed ID: 17651080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
    Kurnatowski P; Makieło L; Horwatt-Bozyczko E
    Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactivity and cellular structure of Candida albicans and Candida glabrata biofilms grown in the presence of fluconazole.
    Gomes PN; da Silva WJ; Pousa CC; Narvaes EA; Del Bel Cury AA
    Arch Oral Biol; 2011 Nov; 56(11):1274-81. PubMed ID: 21549350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms.
    Monteiro DR; Silva S; Negri M; Gorup LF; de Camargo ER; Oliveira R; Barbosa DB; Henriques M
    Mycoses; 2013 Nov; 56(6):672-80. PubMed ID: 23773119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of chlorhexidine on the disinfection of complete dentures colonised with fluconazole-resistant Candida albicans: in vitro study.
    Mima EG; Pavarina AC; Vargas Fda S; Giampaolo ET; Machado AL; Vergani CE
    Mycoses; 2011 Sep; 54(5):e506-12. PubMed ID: 21605178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
    Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L
    Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates.
    Denardi LB; Mario DA; Loreto ÉS; Santurio JM; Alves SH
    Braz J Microbiol; 2015 Mar; 46(1):125-9. PubMed ID: 26221097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model.
    Khodavandi A; Alizadeh F; Harmal NS; Sidik SM; Othman F; Sekawi Z; Jahromi MA; Ng KP; Chong PP
    FEMS Microbiol Lett; 2011 Feb; 315(2):87-93. PubMed ID: 21204918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
    Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
    Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prior colonisation with Candida species fails to guide empirical therapy for candidaemia in critically ill adults.
    Troughton JA; Browne G; McAuley DF; Walker MJ; Patterson CC; McMullan R
    J Infect; 2010 Nov; 61(5):403-9. PubMed ID: 20849877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.